11/02/2015

Presenter: Dr. Youngkyoo Jung, PhD, Assistant Professor, Radiology Brain Tumor Center of Excellence Comprehensive Cancer Center Translational Science Institute, Wake Forest School of Medicine, Winston-Salem, NC
Topic: "Advances in arterial spin labeling MRI"
Where: Laureate Institute for Brain Research, Conference Room A
When: Monday, November 2nd, 2015 at 12 noon

William K. Warren, Jr.  Frontiers in Neuroscience Conference
Laureate Psychiatric Clinic and Hospital Conference Center- October 21, 2015

8:00am - 9:00am    Registration and Breakfast
9:00am - 10:00am  Program
 
Dr. Daniel Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program.  Dr. Pine moved to this position in 2000, after 10 years of training, teaching, and research at Columbia University.  Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 400 peer-reviewed papers.  Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function.   Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and President of the Society of Biological Psychiatry.  He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.

Learning Objectives:

1. understand the key phenomenological distinctions among the varied pediatric anxiety disorders
2. understand the process through which clinical research on therapeutics is informed by basic research in systems neuroscience
3. understand the direction in which ongoing research on therapeutics is moving, from basic research to novel applications through cognitive training.

William K. Warren, Jr.  Frontiers in Neuroscience Conference
Laureate Psychiatric Clinic and Hospital Conference Center- October 16, 2015
 
11:00am - 12:00pm    Registration and Lunch
12:00pm - 1:00pm      Program
 
Kate Fitzgerald, M.D. 
Dr. Kate Fitzgerald received her medical degree from Wayne State University before coming to the University of Michigan to complete her medical residency and fellowship training in child and adolescent psychiatry.  She is now practicing as a child psychiatrist, specializing in the evaluation of treatment of pediatric anxiety and related disorders, such as depression.  She is co-director of the Pediatric Anxiety and Tic Disorders Clinic at the University of Michigan and an assistant professor within the Department of Psychiatry at the University of Michigan.
 
Dr. Fitzgerald's research focuses on neural mechanisms underlying pediatric anxiety, including obsessive compulsive disorder.  Her current research involves using fMRI, EEG, and behavioral assessments to look for biomarkers of anxiety disorders that may serve as targets for novel, mechanism-based treatments.  Currently, she is conducting federally funded research to elucidate developmentally sensitive mechanisms of cognitive behavioral therapy (CBT) for OCD (R01 MH1022420) and to develop a bio-behavior assessment battery for anxiety and depression in preschoolers, based on Research Domain Criteria (R03 MH102648-01).  She is also involved in Medicaid-funded research focusing on the dissemination of currently available cognitive behavioral therapy methods through public schools to reduce anxiety and depression in a community sample of adolescents. 
 
Three Learning Objectives:

1. Review how altered error-processing function may relate to OCD symptoms.     
2. Describe neuroimaging evidence of altered brain response to errors in OCD, including atypical development in pediatric patients.     
3. Discuss how these alterations could be differentially targeted to treat pediatric compared to adult OCD.